Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oxytocin | 15 | 2023 | 124 | 5.360 |
Why?
|
Intimate Partner Violence | 10 | 2021 | 58 | 5.190 |
Why?
|
Stress Disorders, Post-Traumatic | 32 | 2023 | 1506 | 4.290 |
Why?
|
Alcoholism | 13 | 2023 | 1109 | 2.960 |
Why?
|
Crime Victims | 6 | 2021 | 286 | 2.690 |
Why?
|
Veterans | 20 | 2023 | 904 | 2.600 |
Why?
|
Implosive Therapy | 9 | 2021 | 171 | 2.470 |
Why?
|
Substance-Related Disorders | 20 | 2021 | 1242 | 2.320 |
Why?
|
Sex Offenses | 5 | 2021 | 170 | 1.560 |
Why?
|
Craving | 9 | 2022 | 200 | 1.400 |
Why?
|
Oxytocics | 2 | 2019 | 14 | 1.310 |
Why?
|
Couples Therapy | 2 | 2019 | 10 | 1.270 |
Why?
|
Hydrocortisone | 8 | 2022 | 291 | 1.210 |
Why?
|
Alcohol Drinking | 6 | 2021 | 805 | 1.190 |
Why?
|
Stress, Psychological | 9 | 2022 | 824 | 1.180 |
Why?
|
Spouse Abuse | 3 | 2016 | 40 | 1.080 |
Why?
|
Behavior Therapy | 2 | 2019 | 297 | 1.050 |
Why?
|
Administration, Intranasal | 8 | 2022 | 88 | 0.960 |
Why?
|
Sexual Partners | 4 | 2021 | 106 | 0.940 |
Why?
|
Double-Blind Method | 10 | 2023 | 1738 | 0.870 |
Why?
|
Interpersonal Relations | 3 | 2019 | 209 | 0.860 |
Why?
|
Adult | 35 | 2021 | 21403 | 0.850 |
Why?
|
Family Characteristics | 2 | 2020 | 44 | 0.820 |
Why?
|
Humans | 57 | 2023 | 68618 | 0.810 |
Why?
|
Domestic Violence | 1 | 2022 | 36 | 0.810 |
Why?
|
Male | 37 | 2022 | 37321 | 0.740 |
Why?
|
Female | 41 | 2022 | 38074 | 0.740 |
Why?
|
Neuroimaging | 2 | 2019 | 122 | 0.740 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 101 | 0.730 |
Why?
|
Comorbidity | 8 | 2021 | 1426 | 0.720 |
Why?
|
Consumer Health Information | 1 | 2020 | 16 | 0.710 |
Why?
|
Bullying | 1 | 2020 | 28 | 0.700 |
Why?
|
Young Adult | 16 | 2020 | 5717 | 0.700 |
Why?
|
Nerve Net | 2 | 2018 | 181 | 0.690 |
Why?
|
Marijuana Use | 1 | 2020 | 35 | 0.680 |
Why?
|
Parents | 1 | 2022 | 312 | 0.660 |
Why?
|
Stress Disorders, Traumatic, Acute | 1 | 2019 | 8 | 0.660 |
Why?
|
Socioeconomic Factors | 3 | 2020 | 955 | 0.640 |
Why?
|
Treatment Outcome | 16 | 2023 | 7029 | 0.620 |
Why?
|
Negotiating | 1 | 2017 | 18 | 0.610 |
Why?
|
Coronavirus Infections | 1 | 2020 | 143 | 0.580 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 154 | 0.580 |
Why?
|
Pandemics | 1 | 2020 | 352 | 0.550 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2017 | 77 | 0.540 |
Why?
|
Sex Characteristics | 1 | 2018 | 295 | 0.540 |
Why?
|
Precision Medicine | 1 | 2017 | 111 | 0.530 |
Why?
|
Brain | 5 | 2022 | 2176 | 0.530 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2015 | 20 | 0.510 |
Why?
|
Adaptation, Psychological | 3 | 2019 | 447 | 0.510 |
Why?
|
Telemedicine | 2 | 2020 | 700 | 0.500 |
Why?
|
Social Behavior | 1 | 2015 | 164 | 0.470 |
Why?
|
Pregnant Women | 1 | 2014 | 50 | 0.460 |
Why?
|
Avoidance Learning | 1 | 2014 | 58 | 0.460 |
Why?
|
Homicide | 1 | 2014 | 59 | 0.460 |
Why?
|
Combined Modality Therapy | 4 | 2020 | 951 | 0.450 |
Why?
|
Smoking | 3 | 2016 | 1452 | 0.450 |
Why?
|
Mental Health | 2 | 2015 | 278 | 0.430 |
Why?
|
Middle Aged | 17 | 2021 | 21147 | 0.400 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 2022 | 150 | 0.360 |
Why?
|
Pituitary-Adrenal System | 4 | 2022 | 138 | 0.360 |
Why?
|
Cocaine-Related Disorders | 1 | 2015 | 504 | 0.360 |
Why?
|
United States | 7 | 2022 | 7367 | 0.340 |
Why?
|
Opioid-Related Disorders | 3 | 2021 | 298 | 0.330 |
Why?
|
Military Personnel | 3 | 2021 | 221 | 0.320 |
Why?
|
Risk Assessment | 1 | 2014 | 2007 | 0.300 |
Why?
|
Adolescent | 8 | 2022 | 8912 | 0.290 |
Why?
|
Patient Dropouts | 2 | 2018 | 98 | 0.290 |
Why?
|
Pilot Projects | 3 | 2020 | 1342 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 2223 | 0.270 |
Why?
|
Saliva | 4 | 2022 | 142 | 0.250 |
Why?
|
Anger | 2 | 2023 | 47 | 0.250 |
Why?
|
Affective Symptoms | 2 | 2021 | 50 | 0.240 |
Why?
|
Surveys and Questionnaires | 5 | 2019 | 2800 | 0.230 |
Why?
|
Prescription Drugs | 2 | 2015 | 71 | 0.230 |
Why?
|
Diagnosis, Dual (Psychiatry) | 3 | 2018 | 151 | 0.220 |
Why?
|
Galvanic Skin Response | 3 | 2018 | 67 | 0.220 |
Why?
|
Analgesics, Opioid | 2 | 2021 | 498 | 0.220 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 2279 | 0.210 |
Why?
|
Adrenergic alpha-1 Receptor Antagonists | 2 | 2023 | 20 | 0.210 |
Why?
|
Doxazosin | 2 | 2023 | 20 | 0.210 |
Why?
|
Psychological Techniques | 2 | 2021 | 17 | 0.210 |
Why?
|
Ethanol | 2 | 2022 | 893 | 0.210 |
Why?
|
Aggression | 1 | 2022 | 98 | 0.200 |
Why?
|
Parent-Child Relations | 1 | 2022 | 98 | 0.200 |
Why?
|
Sex Factors | 4 | 2020 | 1266 | 0.200 |
Why?
|
Brain Injuries, Traumatic | 1 | 2023 | 105 | 0.190 |
Why?
|
Combat Disorders | 1 | 2021 | 102 | 0.180 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2023 | 142 | 0.180 |
Why?
|
Self Report | 2 | 2020 | 371 | 0.180 |
Why?
|
Drug Users | 1 | 2020 | 10 | 0.180 |
Why?
|
Varenicline | 1 | 2020 | 98 | 0.170 |
Why?
|
Rape | 1 | 2021 | 180 | 0.170 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 58 | 0.170 |
Why?
|
Forensic Medicine | 1 | 2019 | 26 | 0.160 |
Why?
|
Family | 1 | 2021 | 293 | 0.160 |
Why?
|
Marijuana Smoking | 1 | 2020 | 108 | 0.160 |
Why?
|
Stress, Physiological | 1 | 2020 | 215 | 0.160 |
Why?
|
Cigarette Smoking | 1 | 2020 | 104 | 0.160 |
Why?
|
Motivation | 2 | 2021 | 561 | 0.160 |
Why?
|
Psychotropic Drugs | 1 | 2018 | 83 | 0.150 |
Why?
|
Physical Examination | 1 | 2019 | 152 | 0.150 |
Why?
|
Cognition | 1 | 2022 | 513 | 0.150 |
Why?
|
Drug Monitoring | 1 | 2018 | 107 | 0.150 |
Why?
|
Memory, Short-Term | 1 | 2018 | 79 | 0.150 |
Why?
|
Aged | 6 | 2020 | 14862 | 0.150 |
Why?
|
Executive Function | 1 | 2018 | 106 | 0.150 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2017 | 782 | 0.150 |
Why?
|
Random Allocation | 1 | 2018 | 442 | 0.150 |
Why?
|
Mental Health Services | 1 | 2019 | 199 | 0.150 |
Why?
|
Health Surveys | 2 | 2016 | 489 | 0.140 |
Why?
|
Amygdala | 1 | 2018 | 159 | 0.140 |
Why?
|
Severity of Illness Index | 3 | 2017 | 1851 | 0.140 |
Why?
|
Habituation, Psychophysiologic | 1 | 2017 | 22 | 0.140 |
Why?
|
Cocaine | 1 | 2022 | 555 | 0.140 |
Why?
|
Acetylcysteine | 1 | 2020 | 296 | 0.140 |
Why?
|
Prefrontal Cortex | 2 | 2018 | 640 | 0.130 |
Why?
|
Regression Analysis | 1 | 2017 | 737 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 931 | 0.120 |
Why?
|
Follow-Up Studies | 2 | 2018 | 3259 | 0.120 |
Why?
|
Progesterone | 1 | 2014 | 115 | 0.110 |
Why?
|
Social Support | 1 | 2016 | 423 | 0.110 |
Why?
|
Estrogens | 1 | 2014 | 173 | 0.110 |
Why?
|
Child | 2 | 2022 | 6405 | 0.110 |
Why?
|
Cannabis | 1 | 2014 | 115 | 0.110 |
Why?
|
Mental Disorders | 2 | 2015 | 659 | 0.100 |
Why?
|
Depression | 1 | 2019 | 943 | 0.100 |
Why?
|
Emotions | 3 | 2021 | 244 | 0.100 |
Why?
|
Smoking Cessation | 1 | 2020 | 1034 | 0.100 |
Why?
|
Nicotine | 1 | 2014 | 350 | 0.100 |
Why?
|
Anxiety | 1 | 2014 | 422 | 0.100 |
Why?
|
Behavior, Addictive | 1 | 2014 | 317 | 0.090 |
Why?
|
Risk Factors | 1 | 2020 | 5731 | 0.090 |
Why?
|
Prevalence | 3 | 2020 | 1619 | 0.080 |
Why?
|
Pregnancy | 1 | 2014 | 2334 | 0.080 |
Why?
|
Pain | 2 | 2023 | 472 | 0.080 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2021 | 257 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2015 | 1553 | 0.070 |
Why?
|
Heart Rate | 2 | 2015 | 568 | 0.050 |
Why?
|
Prescriptions | 1 | 2021 | 28 | 0.050 |
Why?
|
Tranquilizing Agents | 1 | 2021 | 7 | 0.050 |
Why?
|
Texas | 1 | 2021 | 92 | 0.050 |
Why?
|
Fear | 1 | 2023 | 239 | 0.050 |
Why?
|
Extinction, Psychological | 1 | 2023 | 240 | 0.050 |
Why?
|
Neuroendocrine Cells | 1 | 2020 | 8 | 0.050 |
Why?
|
Neurosecretory Systems | 1 | 2020 | 21 | 0.050 |
Why?
|
Cues | 2 | 2015 | 654 | 0.050 |
Why?
|
Reward | 1 | 2021 | 201 | 0.040 |
Why?
|
Emergencies | 1 | 2019 | 107 | 0.040 |
Why?
|
Blood Pressure | 2 | 2015 | 1451 | 0.040 |
Why?
|
Smokers | 1 | 2020 | 200 | 0.040 |
Why?
|
Functional Neuroimaging | 1 | 2018 | 82 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2018 | 291 | 0.040 |
Why?
|
Survivors | 1 | 2019 | 256 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2020 | 378 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2019 | 383 | 0.040 |
Why?
|
Survival Analysis | 1 | 2018 | 714 | 0.040 |
Why?
|
Veterans Health | 1 | 2017 | 62 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 792 | 0.030 |
Why?
|
Dehydroepiandrosterone | 1 | 2015 | 29 | 0.030 |
Why?
|
New England | 1 | 2015 | 16 | 0.030 |
Why?
|
Age of Onset | 1 | 2015 | 188 | 0.030 |
Why?
|
Age Factors | 1 | 2020 | 1864 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 711 | 0.030 |
Why?
|
Australia | 1 | 2015 | 235 | 0.030 |
Why?
|
Psychological Tests | 1 | 2014 | 96 | 0.030 |
Why?
|
Disabled Persons | 1 | 2015 | 94 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2015 | 106 | 0.030 |
Why?
|
South Carolina | 1 | 2020 | 2752 | 0.030 |
Why?
|
Health Status | 1 | 2015 | 429 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2016 | 1054 | 0.030 |
Why?
|
Logistic Models | 1 | 2016 | 1420 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2015 | 2455 | 0.020 |
Why?
|
Time Factors | 1 | 2017 | 4655 | 0.020 |
Why?
|
Infant | 1 | 2015 | 2891 | 0.020 |
Why?
|
Child, Preschool | 1 | 2015 | 3187 | 0.020 |
Why?
|
Animals | 1 | 2014 | 20881 | 0.010 |
Why?
|